Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Aveir DR i2i Study - Aveir Dual-Chamber Leadless i2i IDE Study

Disease Sites:

Not Available

Staging:

Phase II

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Richardson, Travis

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

04-12-2022

Trial Type:

Treatment

Protocol ID:

CRE-ARR0013

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available